Bukwang Pharmaceutical IND Q3 Operating Profit at ₩2.2B, Up 120% YoY
Predicted impact: Low
Q3 operating profit of 2.2 billion won, up 120%, but tiny versus revenue and market value.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.